Embera NeuroTherapeutics Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Embera NeuroTherapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014068
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Embera NeuroTherapeutics Inc (Embera) is a contract research company that discovers and develops new treatments. The company’s product includes EMB-001, a drug combination for the stress response system and specific brain functions that results in craving and improvement associated with these disorders. It offers preclinical studies, clinical research and clinical trial services. Embera provides products and therapeutics for smoking cessation, cocaine dependence and other addictions. The company operates through other health sciences center to support a cocaine dependence development program. It also provides clinical development and research services. The company operates through its offices in Sudbury and Shreveport. Embera is headquartered in Shreveport, Louisiana, the US.

Embera NeuroTherapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Embera NeuroTherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Embera NeuroTherapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Embera NeuroTherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Embera NeuroTherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Embera NeuroTherapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Embera NeuroTherapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Embera NeuroTherapeutics Raises USD1.9 Million in Series A-2 Financing 10
Embera NeuroTherapeutics Raises USD2.3 Million in Venture Financing 11
Embera NeuroTherapeutics Secures US$4.5 Million In Series A Venture Financing 12
Embera NeuroTherapeutics Inc – Key Competitors 13
Embera NeuroTherapeutics Inc – Key Employees 14
Embera NeuroTherapeutics Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Embera NeuroTherapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Embera NeuroTherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Embera NeuroTherapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Embera NeuroTherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Embera NeuroTherapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Embera NeuroTherapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Embera NeuroTherapeutics Raises USD1.9 Million in Series A-2 Financing 10
Embera NeuroTherapeutics Raises USD2.3 Million in Venture Financing 11
Embera NeuroTherapeutics Secures US$4.5 Million In Series A Venture Financing 12
Embera NeuroTherapeutics Inc, Key Competitors 13
Embera NeuroTherapeutics Inc, Key Employees 14
Embera NeuroTherapeutics Inc, Other Locations 15

★海外企業調査レポート[Embera NeuroTherapeutics Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tsumura & co (4540):企業の財務・戦略的SWOT分析
    Tsumura & co (4540) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Repsol SA (REP):企業の財務・戦略的SWOT分析
    Repsol SA (REP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Braskem SA (BRKM5):企業の財務・戦略的SWOT分析
    Braskem SA (BRKM5) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Reliance Capital Ltd:企業の戦略・SWOT・財務分析
    Reliance Capital Ltd - Strategy, SWOT and Corporate Finance Report Summary Reliance Capital Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Banc of California, Inc.:企業のM&A・事業提携・投資動向
    Banc of California, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banc of California, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Saudi Industrial Investment Group (2250):企業の財務・戦略的SWOT分析
    Summary Saudi Industrial Investment Group (SIIG) is a petrochemical company that invests, improves and develops petrochemical industry. The company produces ethylene, polyethylene, hexene, polypropylene and polystyrene. It also provides benzene, propylene, cyclohexane, motor gasoline blend, and hydr …
  • CKE Restaurants Holdings Inc.:企業の戦略・SWOT・財務分析
    CKE Restaurants Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary CKE Restaurants Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • GEE Group Inc (JOB):企業の財務・戦略的SWOT分析
    Summary GEE Group Inc (GEE) is a provider of professional staffing and recruiting services. The company’s staffing services comprise temporary staffing services, professional placement services, and management services. It provides direct hire, contract, and contract-to-hire services in accounting, …
  • 2020 GeneSystems Inc-医療機器分野:企業M&A・提携分析
    Summary 20/20 GeneSystems Inc (20/20 Gene) is a medical diagnostic company that develops and commercializes diagnostic tests and proteomics products for early disease detection, therapy selection and biodefense applications. The company provides tests in the areas such as personalized medicine, earl …
  • Eiger BioPharmaceuticals Inc (EIGR):企業の財務・戦略的SWOT分析
    Summary Eiger BioPharmaceuticals Inc (Eiger), formerly Celladon Corp is a clinical-stage biopharmaceutical company that focuses on the development and commercializationof novel drugs for the treatment of orphan diseases. The company provides pipeline products such as Lonafarnib and Lambda, which are …
  • Elementis plc (ELM):企業の財務・戦略的SWOT分析
    Elementis plc (ELM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • GN Hearing AS:医療機器:M&Aディール及び事業提携情報
    Summary GN Hearing AS (GN Hearing) formerly, GN ReSound A/S, a subsidiary of GN Store Nord A/S, is a medical equipment company that provides advanced hearing health care solutions. The company offers hearing aids, accessories and related products. It also supplies computerized audiology and hearing …
  • Belfius Bank Sa
    Belfius Bank Sa - Strategy, SWOT and Corporate Finance Report Summary Belfius Bank Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Hansard Global plc:企業の戦略・SWOT・財務情報
    Hansard Global plc - Strategy, SWOT and Corporate Finance Report Summary Hansard Global plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Mace Group Ltd:企業の戦略・SWOT・財務情報
    Mace Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Mace Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Genting Malaysia Berhad:企業の戦略・SWOT・財務情報
    Genting Malaysia Berhad - Strategy, SWOT and Corporate Finance Report Summary Genting Malaysia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Elron Electronic Industries Ltd (ELRNF)-医療機器分野:企業M&A・提携分析
    Summary Elron Electronic Industries Ltd (Elron), a subsidiary of IDB Holding Corp Ltd is a holding company that offers medical devices and technology solutions. The company offers patient care systems for stroke care, microbiology, age-related macular degeneration, orthopedics, and heart diseases. I …
  • Versantis AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Versantis AG (Versantis) is a pharmaceutical company that develops new generation of medicines and diagnostics for treating patients with liver diseases. The company’s pipeline product includes VS-01, a liposomal-based peritoneal dialysis fluid that acts as a clearance enhancer for a large s …
  • Societe Generale S.A.:企業の戦略・SWOT・財務分析
    Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report Summary Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • MidAmerican Energy Co:電力:M&Aディール及び事業提携情報
    Summary MidAmerican Energy Company (MidAmerican Energy), a subsidiary of Berkshire Hathaway Energy, is a regulated electric and natural gas utility company that carries out the generation, transmission and distribution and selling of electricity. The company also undertakes distribution, selling and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆